Traded Oct 30, 2026 · largest single transaction 695
Show all 2 transactions
Oct 30, 2026695
DetailsOfficial recordOct 30, 2026695
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BIIB · NASDAQ · Biotechnology
Biogen (BIIB) · oqro.io/stocks/BIIB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$251.41+0.62 (+0.25%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Including 119 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Traded Oct 30, 2026 · largest single transaction 695
Oct 30, 2026695
DetailsOfficial recordOct 30, 2026695
DetailsOfficial recordInsider filing
Traded Oct 30 · filed 3 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Oct 1 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Oct 2, 2026 · largest single transaction 27
Oct 2, 202627
DetailsOfficial recordInsider filing
Traded Oct 2 · filed 3 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Sep 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Aug 3 – Aug 4, 2026 · largest single transaction ~$121KNot reported under a pre-arranged trading plan
Aug 3, 2026~$121K · 593 sh @ $203.34
DetailsInsider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Jun 9 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Jun 9, 2026 · largest single transaction 2,370
Jun 9, 20262,370
DetailsOfficial recordTraded May 1, 2026 · largest single transaction 939
May 1, 2026939
DetailsOfficial recordInsider filing
Traded May 1 · filed 4 days later
Routine share withholding; mechanical by default.
Traded Apr 1, 2026 · largest single transaction 181
Apr 1, 2026181
DetailsOfficial recordInsider filing
Traded Apr 1 · filed 2 days later
Routine share withholding; mechanical by default.
Insider buying
Their first buy on recordTraded Feb 12 · filed 6 days later
Since the trade +28.6% · S&P 500 +7.2% · to Nov 18
Biogen's Head of Pharm Ops and Tech paid $585 out of pocket for Biogen shares.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Feb 13 · filed 5 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider selling
Traded Feb 9 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade +29.7% · S&P 500 +5.2% · to Nov 18
Biogen's Head of Development sold $532K of Biogen shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Feb 6 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Aug 4, 2026~$119K · 593 sh @ $200.96
DetailsOfficial record0 open-market purchases and 2 open-market sales by insiders of BIIB between Mar 30, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Oct 28, 2026. The data provider lists the next release for Feb 4, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Oct 28, 2026 | None | None | None |
| Jul 29, 2026 | None | None | 2 sales |
| Jul 1, 2026 | None | None | None |
| Apr 29, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies